Generic Medicine Info
Special Precautions
Do not use when vesicles have formed or already broken. Discontinue if no improvement occurs within 2 days of treatment commencement.
Adverse Reactions
Contact dermatitis e.g. increased itching, pain, redness and nodule formation (even after prolonged usage).
CIMS Class
ATC Classification
D06BB02 - tromantadine ; Belongs to the class of topical antivirals used in the treatment of dermatological diseases.
J05AC03 - tromantadine ; Belongs to the class of thiosemicarbazone antivirals. Used in the systemic treatment of viral infections.
Disclaimer: This information is independently developed by CIMS based on tromantadine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in